Severity: Warning
Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 176
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 1034
Function: getPubMedXML
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3152
Function: GetPubMedArticleOutput_2016
File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 316
Function: require_once
Background: An increase in the development of learning deficit occurred during estrogen-deprived periods via the increment of systemic and brain oxidative stress, brain apoptosis, and synaptic dysplasticity. Although estrogen supplementation has been shown to improve the brain function in estrogen-deprived conditions, it can lead to several adverse effects. Therefore, the novel therapeutic approach with minimal side effects to protect brain function in estrogen-deprived conditions should be further investigated. Spermidine is a natural polyamine, which can be obtained orally from diet. In the brain, spermidine attenuated age-induced memory impairment and age-related locomotor activity loss via the modulation of autophagic process. However, the effects of spermidine on brain function in estrogen-deprived conditions have never been investigated.
Method: Eighteen female rats were assigned to sham-operated (Sham; n = 6), or estrogen-deprived group by ovariectomy (OVX; n = 12). Twelve weeks after surgery period, sham was received vehicle (normal saline; SV; n = 6) for additional 8 weeks. OVX groups were divided into two subgroups to receive either vehicle (normal saline; OV; n = 6) or spermidine (20 mg/kg/day; OS; n = 6) for an additional 8 weeks. At the end of the experimental period, all animals were taken to test the learning process with a novel objective location test. After that, blood and brain were collected to determine systemic and brain parameters.
Result: Ovariectomized rats showed the characteristic of estrogen deprivation, as indicated by decreased estradiol level when compared with those of sham rats (p<0.05, Figure 1). Spermidine did not increase the estradiol level of ovariectomized rats. Furthermore, systemic oxidative stress, hippocampal ROS production, hippocampal apoptosis, hippocampal autophagic imbalance, dendritic spine loss, synaptic dysplasticity, and learning deficit were observed in ovariectomized rats (p<0.05, Figure 1). Interestingly, spermidine attenuated these systemic and brain pathologies, which lead to improved learning process in ovariectomized rats (p<0.05, Figure 1).
Conclusion: These findings suggest that spermidine may be another therapeutic approach for improving systemic and brain functions in the case of estrogen deprivation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/alz.084861 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!